CN103751224B - 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 - Google Patents
从蛹虫草中提取抗肿瘤活性组分的方法及其应用 Download PDFInfo
- Publication number
- CN103751224B CN103751224B CN201410041854.4A CN201410041854A CN103751224B CN 103751224 B CN103751224 B CN 103751224B CN 201410041854 A CN201410041854 A CN 201410041854A CN 103751224 B CN103751224 B CN 103751224B
- Authority
- CN
- China
- Prior art keywords
- component
- ethyl acetate
- hexane
- isocratic elution
- elution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 73
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 35
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 41
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 claims abstract description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 33
- 238000010828 elution Methods 0.000 claims abstract description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 10
- 229940041181 antineoplastic drug Drugs 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 7
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 claims abstract description 6
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002244 precipitate Substances 0.000 claims abstract description 5
- 238000010829 isocratic elution Methods 0.000 claims description 48
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000012043 crude product Substances 0.000 claims description 20
- 238000004262 preparative liquid chromatography Methods 0.000 claims description 18
- 238000000338 in vitro Methods 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 15
- 238000012216 screening Methods 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 238000002390 rotary evaporation Methods 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- 210000004043 pneumocyte Anatomy 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 7
- 239000012498 ultrapure water Substances 0.000 claims description 7
- 238000007445 Chromatographic isolation Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000000638 solvent extraction Methods 0.000 claims description 5
- 230000001629 suppression Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000002701 cell growth assay Methods 0.000 claims description 3
- 239000002826 coolant Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 238000003811 acetone extraction Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 239000003814 drug Substances 0.000 description 21
- 238000000605 extraction Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 241000190633 Cordyceps Species 0.000 description 8
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 8
- 229960004397 cyclophosphamide Drugs 0.000 description 8
- 238000003809 water extraction Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- BOSXJGUQRALKDK-UHFFFAOYSA-N 2,6-dimethyldecan-3-ol Chemical compound CCCCC(C)CCC(O)C(C)C BOSXJGUQRALKDK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000118 anti-neoplastic effect Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000000247 postprecipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- XLEKNHGPWVDAMJ-WOUKDFQISA-N (2r,3r,4s,5r)-2-[6-(ethoxyamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(NOCC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O XLEKNHGPWVDAMJ-WOUKDFQISA-N 0.000 description 1
- 241000707825 Argyrosomus regius Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041854.4A CN103751224B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041854.4A CN103751224B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103751224A CN103751224A (zh) | 2014-04-30 |
CN103751224B true CN103751224B (zh) | 2015-12-02 |
Family
ID=50518651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410041854.4A Expired - Fee Related CN103751224B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103751224B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111329871A (zh) * | 2020-03-13 | 2020-06-26 | 贵州贵安精准医学研究院股份有限公司 | 蛹虫草预防和治疗肝癌的产品制备方法及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076623C (zh) * | 1994-07-25 | 2001-12-26 | 林清渊 | 冬虫夏草活性组份及其分离方法 |
CN100488978C (zh) * | 2006-01-24 | 2009-05-20 | 上海市农业科学院 | 一种连续提取北冬虫夏草子实体有效成分的方法 |
CN101307112B (zh) * | 2008-07-07 | 2010-12-15 | 中国科学院微生物研究所 | 一种冬虫夏草发酵菌丝体多糖的提取方法 |
-
2014
- 2014-01-27 CN CN201410041854.4A patent/CN103751224B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103751224A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103800388B (zh) | 一种黄绿蜜环菌抗氧化活性组分的制备方法及其应用 | |
CN109464536A (zh) | 烟草抗肿瘤活性组分的提取方法及其应用 | |
CN109453260A (zh) | 烟草抗肿瘤活性组分的提取方法及其应用 | |
CN106892889B (zh) | 一种中国蜂胶黄酮提取物及制备方法和应用 | |
CN103751225B (zh) | 蛹虫草抗肿瘤活性组分的提取方法及其应用 | |
CN103494843B (zh) | 黄蘑菇标准化组分制法及其在肺癌治疗中的应用 | |
CN103784481B (zh) | 一种从蛹虫草中提取抗肿瘤活性组分的方法及其应用 | |
CN103494844B (zh) | 黄蘑菇标准化组分制法及其在肝癌治疗中的应用 | |
CN103800385A (zh) | 从蛹虫草中提取虫草素组分的方法及其应用 | |
CN103784480B (zh) | 黄绿蜜环菌抗氧化活性组分的制备方法及其应用 | |
CN103751224B (zh) | 从蛹虫草中提取抗肿瘤活性组分的方法及其应用 | |
CN109929006B (zh) | 阿魏菇中麦角甾醇过氧化物的提取方法及应用 | |
CN107365284A (zh) | 一种从红豆杉中提取紫杉醇的方法 | |
CN103623066B (zh) | 一种用于制备抗癌药物的塞北紫堇总生物碱提取物及其应用 | |
CN109999104A (zh) | 烟草抗肿瘤活性组分的提取方法及其应用 | |
CN109589340B (zh) | 蝼蛄提取物在制备治疗三阴乳腺癌药物中的应用 | |
CN109180467B (zh) | 三十四碳-(20,23)-二烯酸的提取方法及其应用 | |
CN105434479A (zh) | 从黄绿蜜环菌中提取抗肿瘤活性组分的方法及其应用 | |
CN105687254A (zh) | 黄绿蜜环菌抗肺癌活性组分的提取方法及其应用 | |
CN105687253A (zh) | 黄绿蜜环菌抗肝癌活性组分的提取方法及其应用 | |
CN105601603B (zh) | 黄绿蜜环菌中染料木素单体化合物的提取方法及其应用 | |
CN105601692A (zh) | 黄绿蜜环菌中麦角甾醇单体化合物的提取方法及其应用 | |
CN105693804B (zh) | 从黄绿蜜环菌中提取麦角甾醇的方法及其应用 | |
CN105601602B (zh) | 黄绿蜜环菌中大豆素单体化合物的提取方法及其应用 | |
CN105601515B (zh) | 从三棱中提取三棱二苯乙炔单体化合物的方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170414 Address after: 550025 Guizhou Province in the New District of Guizhou security comprehensive security zone Patentee after: ACADEMY OF PRECISION MEDICINE, GUIAN, GUIZHOU CO.,LTD. Address before: 300457 Tianjin international economic and Technological Development Zone, Binhai New Area, Tianjin Dongting Road, No. 220, Tianjin international joint Academy of biological medicine experimental building N511 Patentee before: ZHENGYUANTANG (TIANJIN) BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 550025 Guian Comprehensive Bonded Zone, Qianzhong Road, Guian New District, Guizhou Province Patentee after: Guizhou Gui'an precision Medicine Co.,Ltd. Address before: 550025 Guian Comprehensive Bonded Zone, Qianzhong Road, Guian New District, Guizhou Province Patentee before: ACADEMY OF PRECISION MEDICINE, GUIAN, GUIZHOU Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151202 |
|
CF01 | Termination of patent right due to non-payment of annual fee |